Cargando…

Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus

Whereas cortical GAD67 reduction and subsequent GABA level decrease are consistently observed in schizophrenia and depression, it remains unclear how these GABAergic abnormalities contribute to specific symptoms. We modeled cortical GAD67 reduction in mice, in which the Gad1 gene is genetically abla...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolata, Stefan M, Nakao, Kazuhito, Jeevakumar, Vivek, Farmer-Alroth, Emily L, Fujita, Yuko, Bartley, Aundrea F, Jiang, Sunny Zhihong, Rompala, Gregory R, Sorge, Robert E, Jimenez, Dennisse V, Martinowich, Keri, Mateo, Yolanda, Hashimoto, Kenji, Dobrunz, Lynn E, Nakazawa, Kazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916365/
https://www.ncbi.nlm.nih.gov/pubmed/29362511
http://dx.doi.org/10.1038/npp.2017.296
_version_ 1783317001127591936
author Kolata, Stefan M
Nakao, Kazuhito
Jeevakumar, Vivek
Farmer-Alroth, Emily L
Fujita, Yuko
Bartley, Aundrea F
Jiang, Sunny Zhihong
Rompala, Gregory R
Sorge, Robert E
Jimenez, Dennisse V
Martinowich, Keri
Mateo, Yolanda
Hashimoto, Kenji
Dobrunz, Lynn E
Nakazawa, Kazu
author_facet Kolata, Stefan M
Nakao, Kazuhito
Jeevakumar, Vivek
Farmer-Alroth, Emily L
Fujita, Yuko
Bartley, Aundrea F
Jiang, Sunny Zhihong
Rompala, Gregory R
Sorge, Robert E
Jimenez, Dennisse V
Martinowich, Keri
Mateo, Yolanda
Hashimoto, Kenji
Dobrunz, Lynn E
Nakazawa, Kazu
author_sort Kolata, Stefan M
collection PubMed
description Whereas cortical GAD67 reduction and subsequent GABA level decrease are consistently observed in schizophrenia and depression, it remains unclear how these GABAergic abnormalities contribute to specific symptoms. We modeled cortical GAD67 reduction in mice, in which the Gad1 gene is genetically ablated from ~50% of cortical and hippocampal interneurons. Mutant mice showed a reduction of tissue GABA in the hippocampus and cortex including mPFC, and exhibited a cluster of effort-based behavior deficits including decreased home-cage wheel running and increased immobility in both tail suspension and forced swim tests. Since saccharine preference, progressive ratio responding to food, and learned helplessness task were normal, such avolition-like behavior could not be explained by anhedonia or behavioral despair. In line with the prevailing view that dopamine in anterior cingulate cortex (ACC) plays a role in evaluating effort cost for engaging in actions, we found that tail-suspension triggered dopamine release in ACC of controls, which was severely attenuated in the mutant mice. Conversely, ACC dopamine release by progressive ratio responding to reward, during which animals were allowed to effortlessly perform the nose-poking, was not affected in mutants. These results suggest that cortical GABA reduction preferentially impairs the effort-based behavior which requires much effort with little benefit, through a deficit of ACC dopamine release triggered by high-effort cost behavior, but not by reward-seeking behavior. Collectively, a subset of negative symptoms with a reduced willingness to expend costly effort, often observed in patients with schizophrenia and depression, may be attributed to cortical GABA level reduction.
format Online
Article
Text
id pubmed-5916365
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-59163652018-05-01 Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus Kolata, Stefan M Nakao, Kazuhito Jeevakumar, Vivek Farmer-Alroth, Emily L Fujita, Yuko Bartley, Aundrea F Jiang, Sunny Zhihong Rompala, Gregory R Sorge, Robert E Jimenez, Dennisse V Martinowich, Keri Mateo, Yolanda Hashimoto, Kenji Dobrunz, Lynn E Nakazawa, Kazu Neuropsychopharmacology Original Article Whereas cortical GAD67 reduction and subsequent GABA level decrease are consistently observed in schizophrenia and depression, it remains unclear how these GABAergic abnormalities contribute to specific symptoms. We modeled cortical GAD67 reduction in mice, in which the Gad1 gene is genetically ablated from ~50% of cortical and hippocampal interneurons. Mutant mice showed a reduction of tissue GABA in the hippocampus and cortex including mPFC, and exhibited a cluster of effort-based behavior deficits including decreased home-cage wheel running and increased immobility in both tail suspension and forced swim tests. Since saccharine preference, progressive ratio responding to food, and learned helplessness task were normal, such avolition-like behavior could not be explained by anhedonia or behavioral despair. In line with the prevailing view that dopamine in anterior cingulate cortex (ACC) plays a role in evaluating effort cost for engaging in actions, we found that tail-suspension triggered dopamine release in ACC of controls, which was severely attenuated in the mutant mice. Conversely, ACC dopamine release by progressive ratio responding to reward, during which animals were allowed to effortlessly perform the nose-poking, was not affected in mutants. These results suggest that cortical GABA reduction preferentially impairs the effort-based behavior which requires much effort with little benefit, through a deficit of ACC dopamine release triggered by high-effort cost behavior, but not by reward-seeking behavior. Collectively, a subset of negative symptoms with a reduced willingness to expend costly effort, often observed in patients with schizophrenia and depression, may be attributed to cortical GABA level reduction. Nature Publishing Group 2018-05 2018-01-24 /pmc/articles/PMC5916365/ /pubmed/29362511 http://dx.doi.org/10.1038/npp.2017.296 Text en Copyright © 2018 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Original Article
Kolata, Stefan M
Nakao, Kazuhito
Jeevakumar, Vivek
Farmer-Alroth, Emily L
Fujita, Yuko
Bartley, Aundrea F
Jiang, Sunny Zhihong
Rompala, Gregory R
Sorge, Robert E
Jimenez, Dennisse V
Martinowich, Keri
Mateo, Yolanda
Hashimoto, Kenji
Dobrunz, Lynn E
Nakazawa, Kazu
Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus
title Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus
title_full Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus
title_fullStr Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus
title_full_unstemmed Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus
title_short Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus
title_sort neuropsychiatric phenotypes produced by gaba reduction in mouse cortex and hippocampus
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916365/
https://www.ncbi.nlm.nih.gov/pubmed/29362511
http://dx.doi.org/10.1038/npp.2017.296
work_keys_str_mv AT kolatastefanm neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus
AT nakaokazuhito neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus
AT jeevakumarvivek neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus
AT farmeralrothemilyl neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus
AT fujitayuko neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus
AT bartleyaundreaf neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus
AT jiangsunnyzhihong neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus
AT rompalagregoryr neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus
AT sorgeroberte neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus
AT jimenezdennissev neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus
AT martinowichkeri neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus
AT mateoyolanda neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus
AT hashimotokenji neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus
AT dobrunzlynne neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus
AT nakazawakazu neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus